Bruker Executive and Leadership Team

Frank Laukien, the Chairman, President & Chief Executive Officer at Bruker, directs the overarching corporate strategy and global vision for the organization. Overseeing the integration of complex scientific instrumentation across diverse international markets, the Chairman, President & Chief Executive Officer ensures alignment between research initiatives and commercial objectives. This leadership role involves managing the long-term growth trajectory of the company while maintaining a competitive edge in mass spectrometry and magnetic resonance systems. By fostering partnerships with academic institutions and industrial leaders, Frank Laukien drives the expansion of the product portfolio into emerging sectors like renewable energy and advanced diagnostics. The Chairman, President & Chief Executive Officer maintains rigorous standards for operational excellence, ensuring that the global footprint remains robust. Through consistent focus on innovation and market penetration, the executive secures the position of the company as a premier provider of analytical technologies.

Gerald Herman, the Executive VP & Chief Financial Officer at Bruker, manages the fiscal health and capital allocation strategies for the entire enterprise. Overseeing global financial reporting, tax compliance, and investor relations, the Executive VP & Chief Financial Officer ensures the stability of the balance sheet while supporting aggressive research and development investments. This leadership role involves optimizing cost structures across the Bruker Scientific Instruments and Bruker Energy & Supercon Technologies segments to maximize shareholder value. By implementing robust financial controls, Gerald Herman facilitates the scaling of manufacturing operations in the semiconductor and pharmaceutical markets. The Executive VP & Chief Financial Officer coordinates with the board to assess risk and identify opportunities for strategic acquisitions that enhance the technological capabilities of the firm. Through disciplined financial planning, the executive provides the necessary resources to sustain the long-term growth and market leadership of the organization.

Mark Munch, the President at Bruker, executes operational strategies focused on the industrial and semiconductor metrology divisions. Overseeing the development of advanced defect-detection equipment and X-ray systems, the President ensures that manufacturing processes meet the high-precision requirements of global technology clients. This leadership role involves streamlining supply chain logistics and enhancing production efficiency to support the rapid evolution of the semiconductor industry. By aligning engineering output with market demand, Mark Munch drives the commercial success of high-performance materials and spectroscopy tools. The President coordinates cross-functional teams to accelerate the time-to-market for new diagnostic and analytical products. Through a focus on operational scalability and technical excellence, the executive strengthens the market presence of the company in the competitive landscape of industrial instrumentation and advanced materials, ensuring consistent delivery of high-quality solutions to customers worldwide.

Bryce McEuen, the President, Bruker Biomedical Systems at Bruker, leads the strategic development and commercialization of specialized diagnostic and life science instrumentation. Overseeing the portfolio of fluorescence optical microscopy and advanced imaging systems, the President, Bruker Biomedical Systems ensures that the company provides cutting-edge tools for biotechnology and clinical research laboratories. This leadership role involves managing the integration of complex hardware and software solutions to address the evolving needs of the pharmaceutical and healthcare sectors. By driving innovation in molecular imaging and diagnostic workflows, Bryce McEuen expands the reach of the organization into critical clinical environments. The President, Bruker Biomedical Systems collaborates with research partners to translate scientific breakthroughs into practical, high-performance products. Through a dedicated focus on the biomedical market, the executive enhances the impact of the company on global health outcomes and scientific discovery, maintaining a strong competitive advantage in the life sciences industry.